Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Interim Management Statement

22 Mar 2019 09:03

RNS Number : 7109T
British Smaller Companies VCT PLC
22 March 2019
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2018

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2018. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make progress with Total Shareholder Return rising from 219.0 pence per ordinary share to 221.5 pence per ordinary share in the quarter. This is an increase of 2.5 pence per ordinary share.

It is pleasing that at 31 December 2018 net asset value ("NAV") increased to £87.4 million, a rise of £2.2 million, equivalent to 2.6 per cent of the opening NAV, this was driven principally from the realisation of three investments in GTK (Holdco) Limited, Mangar Health Limited and Gill Marine Holdings Limited, which were announced in December 2018. These realisations delivered an increase of £2.5 million over the 30 September 2018 valuations. There were £0.4 million of share buy backs in the period, reducing the net assets, and £0.1 million of other movements which comprised the balance of the increase in NAV.

Performance

The movement in Total Shareholder Return in pence per ordinary share is set out in the table below:

 

 

Pence per

ordinary share

Cumulative dividends to 30 September 2018

 

 

140.4

 

Net Asset Value at 30 September 2018

 

 

78.6

 

Total Shareholder Return at 1 October 2018

 

 

 

219.0

Net underlying increase in portfolio

 

 

2.4

 

Net profit after expenses / share buybacks

 

 

0.1

 

Increase in Total Shareholder Return

 

 

 

2.5

Total Shareholder Return at 31 December 2018

 

 

 

221.5p

      

 

 

31 December 2018

Movement

30 September 2018

Total Shareholder Return (PPS)

221.5p

2.5p

219.0p

Net Assets (£m)

87.4

2.2

85.2

NAV per share (PPS)

81.1p

2.5p

78.6p

Cumulative dividends paid (PPS)

140.4p

-

140.4p

Shares in issue

107,831,751

(521,135)

108,352,886

 

The Total Shareholder Return at 31 December 2018, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 221.5 pence per ordinary share compared to 219.0 pence per ordinary share at 30 September 2018. Cumulative dividends paid were unchanged at 140.4 pence per ordinary share (30 September 2018: 140.4 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 December 2018 was 81.1 pence per ordinary share (30 September 2018: 78.6 pence per ordinary share) representing an increase of 2.5 pence per ordinary share, primarily from the gains on realisations.

Subsequent to the quarter end, the Company paid a special dividend of 7.0 pence per ordinary share.

Shares in issue

On 19 December 2018 the Company purchased 521,135 shares at 75.17 pence at a cost of £0.4 million. These shares are held in treasury.

The number of ordinary shares in issue at 31 December 2018 was 107,831,751 (30 September 2018: 108,352,886). In addition, at 31 December 2018 the Company held 7,335,178 ordinary shares in treasury (30 September 2018: 6,814,043).

As a result of the realisations in December 2018 a special interim dividend, representing the realised gain over the original cost of the investments, of 7.0 pence per ordinary share was paid on 15 February 2019. On the same date 3,166,042 ordinary shares were issued under the Company's DRIS following which the Company's issued share capital consists of 110,997,793 ordinary shares of 10 pence each with voting rights and 7,335,178 ordinary shares of 10 pence each held in treasury.

Net assets

Net assets at 31 December 2018 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

52,648

60.2

Quoted investments at bid price

1,752

2.0

Total investments

54,400

62.2

Listed investment funds

2,385

2.7

Cash and cash equivalents

29,371

33.6

Other net current assets

1,281

1.5

Net assets

87,437

100.0

 

 

The investment portfolio at 31 December 2018 was comprised as follows:

 

Valuation

£000

Valuation as a % of net assets

ACC Aviation

7,872

9.0

Matillion Limited

7,770

8.9

Intelligent Office UK

4,487

5.1

Deep-Secure Ltd

4,053

4.6

Business Collaborator Limited

3,427

3.9

Eikon Holdco Limited

3,120

3.6

KeTech Enterprises Limited

2,329

2.7

Springboard Research Holdings Limited

2,141

2.5

Leengate Holdings Limited

1,860

2.1

Friska Limited

1,812

2.1

 

38,871

44.5

Other investments

15,529

17.7

Total investments

54,400

62.2

 

During the quarter to 31 December 2018 the Company made one follow-on investment of £0.2 million into Traveltek Group Holdings Limited.

Investments made prior to the November 2015 Budget now represent 65 per cent of the value of the unquoted portfolio at 31 December 2018.

In the quarter to 31 December 2018 the realisation and repayment of investments and loans generated proceeds of £16.0 million, including £13.1 million from the realisation of GTK (Holdco) Limited, Mangar Health Limited and Gill Marine Holdings Limited.

Portfolio Performance

As at 31 December 2018 the aggregate unrealised portfolio valuation stood at £54.4 million.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 December 2018, three investments represented more than five per cent of the Company's NAV, the largest being 9.0 per cent, with the top ten investments representing 44.5 per cent of NAV (30 September 2018: 48.1 per cent).

Fundraising

On 27 November 2018 your Company launched a new share offer with British Smaller Companies VCT2 plc to raise in aggregate up to £30 million, with an over-allotment facility of £5 million. I am delighted that due to strong demand the offer closed on 11 February 2019 raising total gross proceeds of £35 million. The allotment of new ordinary shares is expected to take place between 1 and 5 April 2019, subsequent to which your Company will receive net proceeds of approximately £21.5 million.

Regulatory Developments

Since the new rules were introduced in the November 2015 and November 2017 budgets equity instruments have made up 79 per cent of all investments and, due to the cash flow needs of the businesses invested in, the interest on the debt instruments is largely rolled until exit or the loan repayment date. As a result, the Company's income will reduce over time and the payment of interest will be later in an investment's lifetime.

At the time that HMRC published its consultation on improving the advance assurance process in December 2016 its major proposal was to encourage VCTs to self-assure investments where appropriate. There were some concerns that the accompanying HMRC guidance in this area was unclear, particularly with the rectification process around any inadvertent errors. Following discussions between HMRC and the Investment Adviser and other VCT advisers the guidance has been revised and, as a result, the Board has decided to self-assure on investments that, subject to professional advice, clearly meet the tests as a Qualifying Investment.

Outlook

In this financial year your Company has made two new investments and made three highly successful disposals with investments made in the past three years now making up 35 per cent of the unquoted portfolio's value. With a number of portfolio companies in realisation phase and a healthy pipeline of new investment opportunities the portfolio will increasingly comprise younger growth businesses.

Despite the uncertainty around how the UK will leave the EU there has been little impact on your Company's activities and notably the purchasers of the three businesses sold in December 2018 included a UK plc and two overseas buyers. The Board believes that, whilst there may be some direct impact from the UK's withdrawal from the EU on the portfolio, the investee businesses are seeking to take steps to manage this impact; although the portfolio is not immune from the impact that any economic downturn may cause.

The pipeline of new opportunities continues to increase and the decision to self-assure on selected new investments may well help the speed with which opportunities are converted.

The Board wishes to thank existing and new shareholders for making a success of the joint fundraising with British Smaller Companies VCT2 plc.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

22 March 2019

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRTPGURAWUPBURP
Date   Source Headline
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:24 pmRNS1st Quarter Results
10th Sep 20212:06 pmRNSResult of AGM
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising
23rd Jul 202110:35 amRNSDirector/PDMR Shareholding
23rd Jul 202110:34 amRNSPayment of Dividend and Allotment of Shares
25th Jun 20219:28 amRNSTransaction in Own Shares
15th Jun 20211:30 pmRNSAnnual Financial Report
4th May 20219:14 amRNSDirector Declaration - Non-executive appointment
26th Mar 20218:35 amRNSTransaction in Own Shares
12th Mar 202110:55 amRNSInterim Management Statement
8th Mar 20212:20 pmRNSDirector/PDMR Shareholding
8th Mar 20212:19 pmRNSDirector/PDMR Shareholding
8th Mar 20212:10 pmRNSIssue of Equity and Close of Offer
22nd Feb 20214:15 pmRNSClose of Offer to Further Applications
2nd Feb 202110:00 amRNSOffers for Subscription
2nd Feb 202110:00 amRNSOffers for Subscription
28th Jan 20217:00 amRNSNet Asset Value and Proposed Fundraising
15th Dec 202012:02 pmRNSTransaction in Own Shares
11th Dec 20209:30 amRNSProposed Fundraising
11th Dec 20209:30 amRNSProposed Fundraising
25th Nov 20204:00 pmRNSHalf-year Report
5th Oct 20209:53 amRNSIssue of Equity
28th Sep 20207:18 amRNSTransaction in Own Shares
10th Sep 20201:31 pmRNSResult of AGM
28th Aug 20207:50 amRNSAGM Statement
12th Aug 202010:00 amRNSInterim Management Statement to 30 June 2020
31st Jul 20209:36 amRNSPayment of dividend and issue of equity
29th Jun 202011:51 amRNSTransaction in Own Shares
24th Jun 202011:15 amRNSAnnual Financial Report
26th Mar 20204:30 pmRNSNet Asset Value
20th Mar 20204:00 pmRNSTransaction in Own Shares
20th Mar 20204:00 pmRNSPayment of Dividend
20th Mar 20204:00 pmRNSTemporary suspension of DRIS & Buyback policy
11th Feb 20207:19 amRNS3rd Quarter Results and announcement of dividend
19th Dec 201910:18 amRNSTransaction in Own Shares
21st Nov 20191:00 pmRNSHalf-year Report to 30 September 2019
27th Sep 20199:30 amRNSPurchase of Own Securities and Net Asset Value
11th Sep 20192:46 pmRNSAppointment of non-executive directors
11th Sep 201912:55 pmRNSResult of AGM
15th Aug 20193:14 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.